| scholarly article | Q13442814 |
| P2093 | author name string | D Xie | |
| J-J Li | |||
| G-T Liu | |||
| D-P Liu | |||
| P2860 | cites work | Compartmentalized signaling by GPI-anchored ephrin-A5 requires the Fyn tyrosine kinase to regulate cellular adhesion | Q24596866 |
| Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells | Q24655999 | ||
| Ephrin-B2 is a candidate ligand for the Eph receptor, EphB6 | Q28143384 | ||
| The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase | Q28145635 | ||
| Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis | Q28286738 | ||
| The role of ephrins and Eph receptors in cancer | Q28294851 | ||
| Regulation of angiogenesis by Eph-ephrin interactions | Q28306625 | ||
| Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1 | Q29617290 | ||
| Cloning and characterization of the promoter region of the rat epidermal growth factor receptor gene and its transcriptional regulation by nerve growth factor in PC12 cells | Q30843762 | ||
| Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases | Q32062433 | ||
| Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival | Q33245287 | ||
| Chemically diverse toxicants converge on Fyn and c-Cbl to disrupt precursor cell function | Q33273613 | ||
| Catalytic domains of tyrosine kinases determine the phosphorylation sites within c-Cbl | Q33292321 | ||
| Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. | Q34169244 | ||
| Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers | Q34290211 | ||
| Ephrin-As mediate targeting of eye-specific projections to the lateral geniculate nucleus | Q34434701 | ||
| Multiple roles of ephrins during the formation of thalamocortical projections: maps and more | Q35685283 | ||
| Diverse roles of eph receptors and ephrins in the regulation of cell migration and tissue assembly | Q35911289 | ||
| Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours | Q36400537 | ||
| Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas | Q36692599 | ||
| Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling | Q40064482 | ||
| Activation of the EGFR gene target EphA2 inhibits epidermal growth factor-induced cancer cell motility | Q40156318 | ||
| c-Cbl-mediated ubiquitinylation is required for epidermal growth factor receptor exit from the early endosomes | Q40542743 | ||
| A new ephrin-A1 isoform (ephrin-A1b) with altered receptor binding properties abrogates the cleavage of ephrin-A1a. | Q40604541 | ||
| Ephrin-A1 induces c-Cbl phosphorylation and EphA receptor down-regulation in T cells | Q40641471 | ||
| Negative regulation of EphA2 receptor by Cbl. | Q40714708 | ||
| Serine mutations that abrogate ligand-induced ubiquitination and internalization of the EGF receptor do not affect c-Cbl association with the receptor | Q42833869 | ||
| Estrogen suppression of EGFR expression in breast cancer cells: a possible mechanism to modulate growth | Q43676061 | ||
| Human osteosarcoma expresses specific ephrin profiles: implications for tumorigenicity and prognosis. | Q44124165 | ||
| Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways | Q47937413 | ||
| Ephrin-A5 modulates the topographic mapping and connectivity of commissural axons in murine hippocampus | Q48544430 | ||
| Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice | Q79322834 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1759-1768 | |
| P577 | publication date | 2009-03-09 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | EphrinA5 acts as a tumor suppressor in glioma by negative regulation of epidermal growth factor receptor | |
| P478 | volume | 28 |
| Q38683823 | A brief perspective of drug resistance toward EGFR inhibitors: the crystal structures of EGFRs and their variants |
| Q92648079 | BMP10 suppresses hepatocellular carcinoma progression via PTPRS-STAT3 axis |
| Q37580101 | Cell transcriptional state alters genomic patterns of DNA double-strand break repair in human astrocytes |
| Q35783568 | Clinical relevance of Ephs and ephrins in cancer: lessons from breast, colorectal, and lung cancer profiling |
| Q28541231 | Comparison of the cancer gene targeting and biochemical selectivities of all targeted kinase inhibitors approved for clinical use |
| Q55286883 | Differential Expression Patterns of Eph Receptors and Ephrin Ligands in Human Cancers. |
| Q36791708 | EGFRvIV: a previously uncharacterized oncogenic mutant reveals a kinase autoinhibitory mechanism. |
| Q59126382 | EPH receptor A2 governs a feedback loop that activates Wnt/β-catenin signaling in gastric cancer |
| Q38269791 | Eph family co-expression patterns define unique clusters predictive of cancer phenotype |
| Q37122330 | Eph receptor signaling and ephrins |
| Q34021365 | Eph receptors and ephrins in cancer: bidirectional signalling and beyond |
| Q37919431 | Eph receptors and ephrins in neuron-astrocyte communication at synapses |
| Q27000196 | Eph receptors as therapeutic targets in glioblastoma |
| Q26864082 | EphA receptor signaling--complexity and emerging themes |
| Q46756335 | EphA2 and ephrin-A5 are not a receptor-ligand pair in the ocular lens |
| Q36179161 | EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion |
| Q39247599 | EphB4 is overexpressed in gliomas and promotes the growth of glioma cells |
| Q37658786 | Ephrin expression and function in cancer. |
| Q39445033 | EphrinA5 suppresses colon cancer development by negatively regulating epidermal growth factor receptor stability |
| Q27015780 | Ephs and Ephrins in malignant gliomas |
| Q39298204 | Exploration of Involved Key Genes and Signaling Diversity in Brain Tumors |
| Q92617482 | Hypoxia-induced EPHB2 promotes invasive potential of glioblastoma |
| Q38911638 | OncomiR miR-96 and miR-182 promote cell proliferation and invasion through targeting ephrinA5 in hepatocellular carcinoma |
| Q90103333 | PRMT1 promotes pancreatic cancer growth and predicts poor prognosis |
| Q34364217 | Peritumoral small ephrinA5 isoform level predicts the postoperative survival in hepatocellular carcinoma |
| Q39383776 | Podocyte EphB4 signaling helps recovery from glomerular injury. |
| Q92979168 | Polycomb-mediated repression of EphrinA5 promotes growth and invasion of glioblastoma |
| Q26860972 | Role of Eph/ephrin tyrosine kinase in malignant glioma |
| Q90480681 | Scinderin suppresses cell proliferation and predicts the poor prognosis of hepatocellular carcinoma |
| Q64240668 | Silencing of promotes the epithelial-mesenchymal transition of skin squamous cell carcinoma-derived A431 cells |
| Q37644953 | Simultaneous targeting of Eph receptors in glioblastoma |
| Q38006838 | The Eph/Ephrin family in cancer metastasis: communication at the service of invasion |
| Q39000921 | The expression of Wnt-inhibitor DKK1 (Dickkopf 1) is determined by intercellular crosstalk and hypoxia in human malignant gliomas |
| Q38107999 | The role of ubiquitin-proteasome system in glioma survival and growth |
| Q38174793 | Therapeutic targeting of EPH receptors and their ligands |
| Q27334820 | Using regulatory and epistatic networks to extend the findings of a genome scan: identifying the gene drivers of pigmentation in merino sheep |
Search more.